2014 ESC/EACTS guidelines on myocardial revascularization.
暂无分享,去创建一个
G. Filippatos | S. Windecker | J. Knuuti | M. Valgimigli | W. Wijns | G. Stefanini | S. Head | M. Sousa Uva | P. Jüni | Franz‐Josef Neumann | Jochen Cremer | A. Kappetein | Adam Witkowski | Jean-Philippe Collet | Ulf Landmesser | Christian Hamm | Philippe Kolh | Volkmar Falk | Philippe H. Kolh | Fernando Alfonso | Adnan Kastrati | Günther Laufer | Dimitrios J. Richter | Patrick Schauerte | D. Taggart | Lucia Torracca
[1] L. Franzoni. Health at a glance , 2017 .
[2] T. Ivanova,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice , 2016 .
[3] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2016, The Cochrane database of systematic reviews.
[4] Y. Dundar,et al. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. , 2015, The Cochrane database of systematic reviews.
[5] A. Speir,et al. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] S. Silber,et al. Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. , 2014, European heart journal.
[7] C. Di Mario,et al. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries. , 2014, European heart journal.
[8] P. Kolh,et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis , 2014, BMJ : British Medical Journal.
[9] M. Mack,et al. Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial , 2014, Circulation.
[10] S. Saito,et al. A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial , 2014, European heart journal.
[11] H. White,et al. Comparison of four risk scores for contemporary isolated coronary artery bypass grafting. , 2014, Heart, lung & circulation.
[12] V. Falk,et al. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery , 2014, European heart journal.
[13] A. Íñiguez,et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). , 2014, Journal of the American College of Cardiology.
[14] Jeroen J. Bax,et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. , 2014, European heart journal.
[15] R. D. de Winter,et al. Standardizing definitions for hybrid coronary revascularization. , 2014, The Journal of thoracic and cardiovascular surgery.
[16] J. W. Louwerenburg,et al. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial , 2014, The Lancet.
[17] Regina M. Hardison,et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. , 2014, JAMA internal medicine.
[18] M. Akay,et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. , 2014, JAMA internal medicine.
[19] M. Jahangiri,et al. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease. , 2014, The Journal of thoracic and cardiovascular surgery.
[20] B. Kemkes,et al. Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement , 2014, General Thoracic and Cardiovascular Surgery.
[21] Gary S. Mintz,et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study , 2014, Circulation.
[22] P. Serruys,et al. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[23] A. Go,et al. Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries. , 2014, Journal of the American College of Cardiology.
[24] S. Villani,et al. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). , 2014, Journal of the American College of Cardiology.
[25] S. Windecker,et al. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)/stent for life (SFL) groups. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[26] Deepak L. Bhatt,et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. , 2013, JAMA.
[27] Deepak L. Bhatt,et al. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data , 2013, The Lancet.
[28] J. Gillard,et al. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. , 2013, Journal of the American College of Cardiology.
[29] P. Serruys,et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials , 2013, The Lancet.
[30] S. Pocock,et al. Bivalirudin started during emergency transport for primary PCI. , 2013, The New England journal of medicine.
[31] R. Guyton,et al. Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index. , 2013, The Journal of thoracic and cardiovascular surgery.
[32] F. Bakaeen. Endoscopic vein harvest for coronary artery bypass grafting is safe. , 2013, The Journal of surgical research.
[33] V. Fuster,et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. , 2013, The lancet. Diabetes & endocrinology.
[34] B. Fabri,et al. Comparison of the EuroSCORE II and Society of Thoracic Surgeons 2008 risk tools. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[35] Peter L Duffy,et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study , 2013 .
[36] Antonio Colombo,et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.
[37] H. Wijeysundera,et al. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. , 2013, JAMA.
[38] M. Shishehbor,et al. A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. , 2013, Journal of the American College of Cardiology.
[39] G. Schuler,et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.
[40] Mario Fusaro,et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.
[41] Soonchang Hong,et al. Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting. , 2013, The Journal of surgical research.
[42] M. Bots,et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up? , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[43] E. Vicaut,et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). , 2013, The American journal of cardiology.
[44] J. Rouleau,et al. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. , 2013, The Journal of thoracic and cardiovascular surgery.
[45] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[46] V. Fuster,et al. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. , 2013, JAMA.
[47] S. Garcia,et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. , 2013, Journal of the American College of Cardiology.
[48] G. Jensen,et al. Cardiac computed tomography guided treatment strategy in patients with recent acute-onset chest pain: results from the randomised, controlled trial: CArdiac cT in the treatment of acute CHest pain (CATCH). , 2013, International journal of cardiology.
[49] M. Hawn,et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. , 2013, JAMA.
[50] H. Jneid,et al. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. , 2013, International journal of cardiology.
[51] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[52] R. de Caterina,et al. The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. , 2013, International journal of cardiology.
[53] Deepak L. Bhatt,et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. , 2013, The New England journal of medicine.
[54] R. Whitbourn,et al. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). , 2013, JACC. Cardiovascular interventions.
[55] Ajay K. Jain,et al. Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. , 2013, European heart journal.
[56] R. Habib,et al. Late effects of radial artery vs saphenous vein grafting for multivessel coronary bypass surgery in diabetics: a propensity-matched analysis. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[57] V. Falk,et al. Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. , 2013, European heart journal.
[58] V. Falk,et al. Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospects. , 2013, European heart journal.
[59] D. Berman,et al. Noninvasive Fractional Flow Reserve Derived From Computed Tomography Angiography for Coronary Lesions of Intermediate Stenosis Severity: Results From the DeFACTO Study , 2013, Circulation. Cardiovascular imaging.
[60] K. Huber,et al. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention , 2013, European heart journal.
[61] C. V. van Mieghem,et al. Fractional Flow Reserve–Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2013, Circulation.
[62] C. Berry,et al. Randomized trial of preventive angioplasty in myocardial infarction. , 2013, The New England journal of medicine.
[63] E. Vicaut,et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. , 2013, The New England journal of medicine.
[64] R. Lange,et al. The German Aortic Valve Registry (GARY): in-hospital outcome , 2013, European heart journal.
[65] F. Mohr,et al. Impact of Expeditious Management of Perioperative Myocardial Ischemia in Patients Undergoing Isolated Coronary Artery Bypass Surgery , 2013, Circulation.
[66] E. Bates,et al. Time to treatment in patients with STEMI. , 2013, The New England journal of medicine.
[67] A. Íñiguez,et al. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial , 2013, Circulation.
[68] R. Torguson,et al. Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[69] Amir Lerman,et al. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. , 2013, European heart journal.
[70] R. Whitbourn,et al. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[71] B. Medalion,et al. Long-term outcomes of patients with diabetes receiving bilateral internal thoracic artery grafts. , 2013, The Journal of thoracic and cardiovascular surgery.
[72] E. Hess,et al. Triple rule-out computed tomographic angiography for chest pain: a diagnostic systematic review and meta-analysis. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[73] R. Virmani,et al. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[74] S. Kaul,et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. , 2013, European heart journal.
[75] B. Gersh,et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? , 2013, The Lancet.
[76] Peter L Duffy,et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.
[77] G. Stone,et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. , 2013, Journal of the American College of Cardiology.
[78] P. Serruys,et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. , 2013, JACC. Cardiovascular interventions.
[79] Eric Vicaut,et al. Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial , 2013 .
[80] R. Schnabel,et al. Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. , 2013, International journal of cardiology.
[81] K. Swedberg,et al. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials. , 2013, European heart journal.
[82] B. Uretsky,et al. Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data , 2013, Journal of the American Heart Association.
[83] H. Ulmer,et al. Simple adaptations of surgical technique to critically reduce the risk of postoperative sternal complications in patients receiving bilateral internal thoracic arteries. , 2013, Interactive cardiovascular and thoracic surgery.
[84] S. Maes,et al. Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.
[85] A. Pereira,et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. , 2013, American heart journal.
[86] S. Girotra,et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. , 2013, JACC. Cardiovascular interventions.
[87] D. Taggart,et al. A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting. , 2013, Annals of cardiothoracic surgery.
[88] J. Tatoulis. Total arterial coronary revascularization-patient selection, stenoses, conduits, targets. , 2013, Annals of cardiothoracic surgery.
[89] B. Lytle,et al. Endoscopic radial artery harvesting procedure for coronary artery bypass grafting. , 2013, Annals of cardiothoracic surgery.
[90] B. Lytle. Bilateral internal thoracic artery grafting. , 2013, Annals of cardiothoracic surgery.
[91] Deepak L. Bhatt,et al. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. , 2013, Journal of the American College of Cardiology.
[92] T. Akasaka,et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. , 2013, Journal of the American College of Cardiology.
[93] L. Fauchier,et al. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation , 2013, Thrombosis and Haemostasis.
[94] M. Niemelä,et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. , 2013, Journal of the American College of Cardiology.
[95] E. Tuzcu,et al. Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. , 2013, Journal of the American College of Cardiology.
[96] H. Suryapranata,et al. A meta-analytic overview of thrombectomy during primary angioplasty. , 2013, International journal of cardiology.
[97] Shengshou Hu,et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. , 2013, Journal of the American College of Cardiology.
[98] G. Lip,et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. , 2013, European heart journal.
[99] C. Yancy,et al. Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease , 2013, Circulation.
[100] Á. Ferraz,et al. Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: meta-analysis and meta-regression of 4817 patients. , 2013, Interactive cardiovascular and thoracic surgery.
[101] Iain Buchan,et al. Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[102] P. Damman,et al. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure , 2013, Journal of cardiovascular medicine.
[103] A. Kastrati,et al. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. , 2013, Journal of the American College of Cardiology.
[104] A. Parkhomenko,et al. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). , 2013, Journal of the American College of Cardiology.
[105] M. Cerqueira,et al. Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction: Inducible Ischemia Versus Hibernating Myocardium , 2013, Circulation. Cardiovascular imaging.
[106] P. Serruys,et al. New concepts in the design of drug-eluting coronary stents , 2013, Nature Reviews Cardiology.
[107] M. Mack,et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[108] A. Akar,et al. Comparison of original EuroSCORE, EuroSCORE II and STS risk models in a Turkish cardiac surgical cohort. , 2013, Interactive cardiovascular and thoracic surgery.
[109] V. Fuster,et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials. , 2013, Journal of the American College of Cardiology.
[110] L. Kuramoto,et al. The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: a population-based observational study , 2013, Journal of Cardiothoracic Surgery.
[111] P. Serruys,et al. Revascularization strategies in patients with diabetes. , 2013, The New England journal of medicine.
[112] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[113] Gregg W Stone,et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. , 2013, The New England journal of medicine.
[114] W. Boden,et al. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris. , 2013, The Canadian journal of cardiology.
[115] E. Hannan,et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. , 2013, The Annals of thoracic surgery.
[116] R. Whitbourn,et al. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. , 2013, JACC. Cardiovascular interventions.
[117] M. Poullis,et al. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[118] J. Stehli,et al. Registry for the Evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT). , 2013, European heart journal cardiovascular Imaging.
[119] Tom Adriaenssens,et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.
[120] S. Yusuf,et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. , 2013, The New England journal of medicine.
[121] A. Diegeler,et al. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. , 2013, The New England journal of medicine.
[122] Neville Kukreja,et al. Use of thrombectomy devices in primary percutaneous coronary intervention: a systematic review and meta-analysis. , 2013, International journal of cardiology.
[123] Raimund Erbel,et al. Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial , 2013, The Lancet.
[124] J. Schwitter,et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.
[125] C. Di Mario,et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[126] A. Gitt,et al. NEWLY DIAGNOSED DIABETES AND PREDIABETES IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION PREDICTS ADVERSE OUTCOMES DURING A THREE-YEAR FOLLOW-UP: RESULTS OF THE SWEETHEART REGISTRY , 2013 .
[127] P. Erwin,et al. Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. , 2013, The Annals of thoracic surgery.
[128] P. Serruys,et al. CT-SYNTAX score: a feasibility and reproducibility Study. , 2013, JACC. Cardiovascular imaging.
[129] M. Mamas,et al. Influence of access site choice on incidence of neurologic complications after percutaneous coronary intervention. , 2013, American heart journal.
[130] Ri-tai Huang,et al. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[131] P. Erwin,et al. Dual Anti‐platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta‐Analysis , 2013, Journal of cardiac surgery.
[132] Y. Liu,et al. Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[133] Yeong-Hoon Choi,et al. Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. , 2013, The Journal of surgical research.
[134] L. M. Maroto Castellanos,et al. Validation of EuroSCORE II on a single-centre 3800 patient cohort. , 2013, Interactive cardiovascular and thoracic surgery.
[135] T. Mihaljevic,et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. , 2013, Journal of the American College of Cardiology.
[136] D. Reda,et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. , 2013, Journal of the American College of Cardiology.
[137] Antonio Colombo,et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II , 2013, The Lancet.
[138] M. Togni,et al. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial , 2013, The Lancet.
[139] C. Terkelsen,et al. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial , 2013, The Lancet.
[140] Antonio Colombo,et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial , 2013, The Lancet.
[141] G. Stone,et al. Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes , 2013, Annals of Internal Medicine.
[142] P. Bagos,et al. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease , 2013, Circulation.
[143] D. Berman,et al. Usefulness of coronary computed tomography angiography to predict mortality and myocardial infarction among Caucasian, African and East Asian ethnicities (from the CONFIRM [Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter] Registry). , 2013, The American journal of cardiology.
[144] A. Kastrati,et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.
[145] Samin K. Sharma,et al. Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular interventions.
[146] S. Hahn,et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. , 2013, American heart journal.
[147] J. Lock,et al. Transcatheter Closure of Post-myocardial Infarction Ventricular Septal Rupture , 2013, Circulation. Cardiovascular interventions.
[148] Robert L Kormos,et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[149] J. Messenger,et al. Clinical ResearchInterventional CardiologyThe Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis From the National Cardiovascular Data Registry (2007 to 2011) , 2013 .
[150] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[151] Michail I. Papafaklis,et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. , 2013, Journal of the American College of Cardiology.
[152] L. Räber,et al. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[153] B. Lytle,et al. Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation. , 2013, Journal of the American College of Cardiology.
[154] G. Knapp,et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials , 2013, Heart.
[155] D. Holmes,et al. Drug-eluting coronary-artery stents. , 2013, The New England journal of medicine.
[156] M. Pencina,et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. , 2013, Journal of the American College of Cardiology.
[157] M. Lubberink,et al. Hybrid Imaging Using Quantitative H215O PET and CT-Based Coronary Angiography for the Detection of Coronary Artery Disease , 2013, The Journal of Nuclear Medicine.
[158] M. Morice,et al. Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[159] G. Montalescot,et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. , 2012, JAMA.
[160] G. Dangas,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.
[161] A. Colombo,et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. , 2012, Journal of the American College of Cardiology.
[162] P. Kurlansky,et al. Bilateral Internal Mammary Artery Grafting Enhances Survival in Diabetic Patients: A 30-Year Follow-Up of Propensity Score–Matched Cohorts , 2012, Circulation.
[163] W. Winkelmayer,et al. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. , 2012, Journal of the American Society of Nephrology : JASN.
[164] A. Kastrati,et al. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. , 2012, European heart journal.
[165] G. Friedrich,et al. Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results. , 2012, The Annals of thoracic surgery.
[166] E. Blackstone,et al. Weighting composite endpoints in clinical trials: essential evidence for the heart team. , 2012, The Annals of thoracic surgery.
[167] D. Berman,et al. All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) , 2012, European heart journal.
[168] E. Vicaut,et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. , 2012, The New England journal of medicine.
[169] P. Serruys,et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[170] Giuseppe Biondi-Zoccai,et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[171] Jun-Jie Zhang,et al. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[172] J. Pepper,et al. Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial , 2012, Circulation.
[173] D. Foley,et al. Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial. , 2012, Journal of the American College of Cardiology.
[174] G. Stone,et al. Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. , 2012, Journal of the American College of Cardiology.
[175] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[176] Jeong Hoon Yang,et al. Randomized comparison of conservative versus aggressive strategy for provisional side branch intervention in coronary bifurcation lesions: results from the SMART-STRATEGY (Smart Angioplasty Research Team-Optimal Strategy for Side Branch Intervention in Coronary Bifurcation Lesions) randomized trial. , 2012, JACC. Cardiovascular interventions.
[177] A. Seth,et al. A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients. , 2012, Indian heart journal.
[178] R. Habib,et al. Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients. , 2012, The Annals of thoracic surgery.
[179] Howard K. Song,et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.
[180] Craig I. Coleman,et al. Diagnostic Accuracy of Cardiac Positron Emission Tomography Versus Single Photon Emission Computed Tomography for Coronary Artery Disease: A Bivariate Meta-Analysis , 2012, Circulation. Cardiovascular imaging.
[181] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[182] N. Parakh. Intraaortic balloon support for myocardial infarction with cardiogenic shock , 2012 .
[183] G. Wells,et al. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. , 2012, Journal of the American College of Cardiology.
[184] P. Serruys,et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial , 2012, The Lancet.
[185] C. Held,et al. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. , 2012, Journal of the American College of Cardiology.
[186] Regina M. Hardison,et al. Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial , 2012, Circulation.
[187] P. Teirstein,et al. Left main percutaneous coronary intervention. , 2012, Journal of the American College of Cardiology.
[188] Joris A H de Groot,et al. Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions , 2012, Heart.
[189] Jeroen J. Bax,et al. Third universal definition of myocardial infarction. , 2012, European heart journal.
[190] E. Steyerberg,et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. , 2012, European heart journal.
[191] R. Blankstein,et al. Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.
[192] Deepak L. Bhatt,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. , 2012, The New England journal of medicine.
[193] K. Anstrom,et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. , 2012, JACC. Cardiovascular interventions.
[194] D. Gao,et al. Meta‐analysis of amiodarone versus beta‐blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery , 2012, Internal medicine journal.
[195] O. Alfieri,et al. Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.
[196] D. Atar,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. , 2012, European heart journal.
[197] L. Bonati,et al. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. , 2012, The Cochrane database of systematic reviews.
[198] Nikola Jagic,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.
[199] C. Herzog,et al. Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease , 2012, Circulation.
[200] M. Pasque,et al. Radial Artery Free and T Graft Patency as Coronary Artery Bypass Conduit Over a 15-Year Period , 2012, Circulation.
[201] Takeshi Kimura,et al. Benefits of Off-Pump Coronary Artery Bypass Grafting in High-Risk Patients , 2012, Circulation.
[202] J. Gummert,et al. Clampless Off-Pump Versus Conventional Coronary Artery Revascularization: A Propensity Score Analysis of 788 Patients , 2012, Circulation.
[203] D. Hoffman,et al. Coronary Artery Bypass Grafting Using the Radial Artery: Clinical Outcomes, Patency, and Need for Reintervention , 2012, Circulation.
[204] L. Køber,et al. Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study , 2012, Circulation.
[205] T. Vassiliades,et al. Bilateral internal thoracic artery grafting is associated with significantly improved long-term survival, even among diabetic patients. , 2012, The Annals of thoracic surgery.
[206] R. Tölg,et al. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.
[207] Marissa Miller,et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.
[208] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.
[209] A. Kirtane,et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials , 2012, BMJ : British Medical Journal.
[210] Sean M. O'Brien,et al. Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. , 2012, JAMA.
[211] D. Berman,et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. , 2012, American heart journal.
[212] Seung‐Jung Park,et al. Comparative long‐term efficacy and safety of drug‐eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[213] J. Harnek,et al. Comparison of two drug-eluting balloons: a report from the SCAAR registry. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[214] G. Lip,et al. Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score ? , 2012 .
[215] L. Chawla,et al. Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. , 2012, Journal of the American Society of Nephrology : JASN.
[216] J. Fraser,et al. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. , 2012, The Annals of thoracic surgery.
[217] S. Bangalore,et al. Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials , 2012, Circulation. Cardiovascular interventions.
[218] M. Böhm,et al. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[219] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[220] P. Smits,et al. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial. , 2012, Journal of the American College of Cardiology.
[221] Munich,et al. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy. , 2012, Journal of the American College of Cardiology.
[222] G. Weerakkody,et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. , 2012, Journal of the American College of Cardiology.
[223] J. Fleg,et al. Coronary CT angiography versus standard evaluation in acute chest pain. , 2012, The New England journal of medicine.
[224] C. Macaya,et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis , 2012, Heart.
[225] H. Schaff,et al. Multiple Arterial Grafts Improve Late Survival of Patients Undergoing Coronary Artery Bypass Graft Surgery: Analysis of 8622 Patients With Multivessel Disease , 2012, Circulation.
[226] M. Sabatine,et al. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2012, Journal of the American College of Cardiology.
[227] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[228] A. Laupacis,et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). , 2012, Journal of the American College of Cardiology.
[229] J. Andreasen,et al. Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[230] S. James,et al. Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts. , 2012, American heart journal.
[231] P. Stella,et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-mont , 2012, Journal of the American College of Cardiology.
[232] J. Messenger,et al. Off-Pump Coronary Artery Bypass Surgery Is Associated With Worse Arterial and Saphenous Vein Graft Patency and Less Effective Revascularization: Results From the Veterans Affairs Randomized On/Off Bypass (ROOBY) Trial , 2012, Circulation.
[233] Deepak L. Bhatt,et al. Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials , 2012, Circulation.
[234] G. Stone,et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placem , 2012, Journal of the American College of Cardiology.
[235] B. Linden. On-pump vs off-pump CABG , 2012 .
[236] M. Mack,et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. , 2012, JACC. Cardiovascular interventions.
[237] F. Biancari,et al. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. , 2012, The Annals of thoracic surgery.
[238] K. Werdan,et al. Intra-aortic balloon counterpulsation in the treatment of infarction-related cardiogenic shock--review of the current evidence. , 2012, Artificial organs.
[239] K. Kern. Optimal treatment of patients surviving out-of-hospital cardiac arrest. , 2012, JACC. Cardiovascular interventions.
[240] N. Bruining,et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures , 2012, European heart journal.
[241] B. Gersh,et al. Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2012, Circulation.
[242] Krzysztof Wróbel,et al. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial , 2012, Circulation.
[243] Samin K. Sharma,et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. , 2012, Journal of the American College of Cardiology.
[244] Susanne Nørgaard Madsen,et al. On-Pump Versus Off-Pump Coronary Artery Bypass Surgery in Elderly Patients: Results From the Danish On-Pump Versus Off-Pump Randomization Study , 2012, Circulation.
[245] G. Stone,et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. , 2012, JAMA.
[246] H. Jneid,et al. Clinical Outcomes of Percutaneous Interventions in Saphenous Vein Grafts Using Drug‐Eluting Stents Compared to Bare‐Metal Stents: A Comprehensive Meta‐Analysisof All Randomized Clinical Trials , 2012, Clinical cardiology.
[247] M. Valgimigli,et al. Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. , 2012, American heart journal.
[248] P. Serruys,et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. , 2012, European heart journal.
[249] H. Luckraz,et al. Heart team discussion in managing patients with coronary artery disease: outcome and reproducibility. , 2012, Interactive cardiovascular and thoracic surgery.
[250] P. Serruys,et al. Seven‐year safety and efficacy of the unrestricted use of drug‐eluting stents in saphenous vein bypass grafts , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[251] F. Dagenais,et al. Completeness of revascularization and survival among octogenarians with triple-vessel disease. , 2012, The Annals of thoracic surgery.
[252] G. Stone,et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. , 2012, Archives of internal medicine.
[253] Sean M. O'Brien,et al. Comparative effectiveness of revascularization strategies. , 2012, The New England journal of medicine.
[254] S. Yusuf,et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. , 2012, The New England journal of medicine.
[255] Samin K. Sharma,et al. Comparative Outcomes for Patients Who Do and Do Not Undergo Percutaneous Coronary Intervention for Stable Coronary Artery Disease in New York , 2012, Circulation.
[256] G. Stone,et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis , 2012, The Lancet.
[257] B. Dai,et al. Efficacy of Short-Term High-Dose Statin in Preventing Contrast-Induced Nephropathy: A Meta-Analysis of Seven Randomized Controlled Trials , 2012, PLoS ONE.
[258] J. Fajadet,et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. , 2012, Journal of the American College of Cardiology.
[259] K. Hauptmann,et al. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. , 2012, Journal of the American College of Cardiology.
[260] J. W. Louwerenburg,et al. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. , 2012, Journal of the American College of Cardiology.
[261] J. Brachmann,et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. , 2012, Journal of the American College of Cardiology.
[262] A. Hughes,et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. , 2012, Journal of the American College of Cardiology.
[263] R. Hetzer,et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. , 2012, Interactive cardiovascular and thoracic surgery.
[264] P. Rehak,et al. Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) Study , 2012, Circulation. Cardiovascular interventions.
[265] G. Ferrari,et al. Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: validation of a contemporary surgical experience. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[266] P. Kurlansky,et al. Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up. , 2012, The Journal of thoracic and cardiovascular surgery.
[267] M. Carrier,et al. Management of early postoperative coronary artery bypass graft failure. , 2012, Interactive cardiovascular and thoracic surgery.
[268] Sudeshna Banerjee,et al. Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. , 2012, The American journal of cardiology.
[269] Rolf H H Groenwold,et al. Performance of the original EuroSCORE. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[270] Ajay K. Jain,et al. Successful recanalization of chronic total occlusions is associated with improved long-term survival. , 2012, JACC. Cardiovascular interventions.
[271] Marco Valgimigli,et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. , 2012, European heart journal.
[272] K. Huber,et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial , 2012, Clinical Research in Cardiology.
[273] Sean M. O'Brien,et al. Prediction of Long-Term Mortality After Percutaneous Coronary Intervention in Older Adults: Results From the National Cardiovascular Data Registry , 2012, Circulation.
[274] Sean M. O'Brien,et al. Predictors of Long-Term Survival After Coronary Artery Bypass Grafting Surgery: Results From the Society of Thoracic Surgeons Adult Cardiac Surgery Database (The ASCERT Study) , 2012, Circulation.
[275] J. Marchesini,et al. Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial , 2012, Circulation.
[276] Akiko Maehara,et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.
[277] G. Wright,et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. , 2012, Journal of the American College of Cardiology.
[278] G. Schuler,et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial , 2012, The Lancet.
[279] M. Mack,et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[280] S. Bailey,et al. A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial. , 2012, Cardiovascular revascularization medicine : including molecular interventions.
[281] D. Taggart. Incomplete revascularization: appropriate and inappropriate. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[282] P. Serruys,et al. Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[283] M. Böhm,et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2012, JACC. Cardiovascular interventions.
[284] K. Park,et al. Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: major epicardial vessel versus side branch ostial lesions. , 2012, JACC. Cardiovascular interventions.
[285] D. Dvir,et al. Drug eluting stenting in bifurcation coronary lesions long‐term results applying a systematic treatment strategy , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[286] T. Fuchs,et al. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[287] M. Pfisterer,et al. Coronary artery disease progression late after successful stent implantation. , 2012, Journal of the American College of Cardiology.
[288] David L. Brown,et al. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. , 2012, Archives of internal medicine.
[289] C. Reid,et al. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. , 2012, The American journal of cardiology.
[290] G. Richardt,et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. , 2012, The American journal of cardiology.
[291] E. Vicaut,et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[292] L. Klassen,et al. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. , 2012, The Annals of thoracic surgery.
[293] J. Kelder,et al. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[294] Robert L Kormos,et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[295] E. Yow,et al. Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. , 2012, The Annals of thoracic surgery.
[296] J. Spertus,et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. , 2012, JACC. Cardiovascular interventions.
[297] Craig R. Smith,et al. Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network. , 2012, The Journal of thoracic and cardiovascular surgery.
[298] V. Aboyans,et al. ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases , 2012 .
[299] M. Jeong,et al. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study , 2012, Circulation.
[300] C. Schindler,et al. Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. , 2012, European heart journal.
[301] M. Price,et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. , 2012, JAMA.
[302] Paul Burton,et al. Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.
[303] E. Braunwald,et al. A tale of coronary artery disease and myocardial infarction. , 2012, The New England journal of medicine.
[304] I. Mrdović,et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial , 2012, Coronary artery disease.
[305] T. Mesana,et al. Is Bilateral Internal Thoracic Artery Use Safe in the Elderly? , 2012, Journal of cardiac surgery.
[306] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.
[307] T. Henry,et al. Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase , 2011, Circulation.
[308] U. Khot,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[309] M. Winniford,et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Circulation.
[310] F. Eberli,et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial , 2011, The Lancet.
[311] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[312] D. Dudek,et al. Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.
[313] B. Seifert,et al. Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting. , 2011, The Journal of thoracic and cardiovascular surgery.
[314] G. Stone,et al. SYNTAX Score Reproducibility and Variability Between Interventional Cardiologists, Core Laboratory Technicians, and Quantitative Coronary Measurements , 2011, Circulation. Cardiovascular interventions.
[315] R. de Caterina,et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. , 2011, European heart journal.
[316] A. Davies,et al. Chapter III: Management of cardiovascular risk factors and medical therapy. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[317] J. Smith,et al. Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2011, European heart journal.
[318] T. Lauer,et al. Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .
[319] H. Krumholz,et al. National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. , 2011, Archives of internal medicine.
[320] A. Kastrati,et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. , 2011, The New England journal of medicine.
[321] F. Van de Werf,et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. , 2011, European heart journal.
[322] R. Hetzer,et al. Late wound healing problems after use of BioGlue for apical hemostasis during transapical aortic valve implantation. , 2011, Interactive cardiovascular and thoracic surgery.
[323] A. Dunning,et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. , 2011, Journal of the American College of Cardiology.
[324] Li-jun Guo,et al. The relationship between kidney function and angiographically-derived SYNTAX score. , 2011, The Canadian journal of cardiology.
[325] C. Don,et al. Carotid revascularization immediately before urgent cardiac surgery practice patterns associated with the choice of carotid artery stenting or endarterectomy: a report from the CARE (Carotid Artery Revascularization and Endarterectomy) registry. , 2011, JACC. Cardiovascular interventions.
[326] A. Moss,et al. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long‐Term Survival in the MADIT‐II Trial , 2011, Journal of cardiovascular electrophysiology.
[327] S. Silber,et al. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[328] K. Anstrom,et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. , 2011, Journal of the American College of Cardiology.
[329] A. Colombo,et al. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. , 2011, The American journal of cardiology.
[330] Samin K. Sharma,et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. , 2011, Journal of the American College of Cardiology.
[331] M. Leoncini,et al. Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary Angioplasty: A Randomized, Controlled Trial , 2011, Circulation. Cardiovascular interventions.
[332] W. Ghali,et al. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. , 2011, The Annals of thoracic surgery.
[333] Deepak L. Bhatt,et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary , 2011, Circulation. Cardiovascular interventions.
[334] P. Serruys,et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[335] Benjamin Sohmer,et al. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a case-matched study. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[336] G. Stone,et al. Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. , 2011, The American journal of cardiology.
[337] J. Birkmeyer,et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. , 2011, JAMA.
[338] G. Stone,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. , 2011, Journal of the American College of Cardiology.
[339] Betti Giusti,et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. , 2011, JAMA.
[340] M. Jeong,et al. Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry , 2011, Heart.
[341] H. Ulmer,et al. Second Internal Thoracic Artery Versus Radial Artery in Coronary Artery Bypass Grafting: A Long-Term, Propensity Score–Matched Follow-Up Study , 2011, Circulation.
[342] A. Kastrati,et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial , 2011, The Lancet.
[343] H. Schuchlenz,et al. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. , 2011, European heart journal.
[344] Act Investigators. Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.
[345] M. Valgimigli,et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury , 2011, Circulation.
[346] G. Stone,et al. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. , 2011, JACC. Cardiovascular interventions.
[347] P. Serruys,et al. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[348] B. Iung,et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[349] M. Noc,et al. Angiographic characteristics of coronary disease and postresuscitation electrocardiograms in patients with aborted cardiac arrest outside a hospital. , 2011, The American journal of cardiology.
[350] J. Tu,et al. Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study. , 2011, JACC. Cardiovascular interventions.
[351] P. Wenaweser,et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[352] G. Lip,et al. RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome , 2011, European heart journal.
[353] Deepak L. Bhatt,et al. Apixaban with antiplatelet therapy after acute coronary syndrome. , 2011, The New England journal of medicine.
[354] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.
[355] Mouaz Al-Mallah,et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without know , 2011, Journal of the American College of Cardiology.
[356] D. Holmes,et al. Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis , 2011 .
[357] B. Gersh,et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. , 2011, Journal of the American College of Cardiology.
[358] M. Allessie,et al. Post-operative atrial fibrillation: a maze of mechanisms , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[359] A. Kastrati,et al. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. , 2011, Circulation.
[360] M. Misfeld,et al. Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8 studies. , 2011, The Journal of thoracic and cardiovascular surgery.
[361] D. Atar,et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.
[362] T. Lüscher,et al. Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease , 2011, European heart journal.
[363] S. Ebrahim,et al. Exercise-based cardiac rehabilitation for coronary heart disease. , 2011, The Cochrane database of systematic reviews.
[364] B. Buxton,et al. The right internal thoracic artery: the forgotten conduit--5,766 patients and 991 angiograms. , 2011, The Annals of thoracic surgery.
[365] Seung‐Jung Park,et al. Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.
[366] B. Gersh,et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial , 2011, The Lancet.
[367] H. Krumholz,et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. , 2011, JAMA.
[368] G. Stone,et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. , 2011, Journal of the American College of Cardiology.
[369] J. Jokinen,et al. Clinical value of intra-operative transit-time flow measurement for coronary artery bypass grafting: a prospective angiography-controlled study. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[370] D. Taggart,et al. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[371] Li-sheng Liu,et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. , 2011, European heart journal.
[372] R. Guyton,et al. Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial. , 2011, The Annals of thoracic surgery.
[373] L. Husmann,et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. , 2011, European heart journal.
[374] Seung‐Jung Park,et al. Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease , 2011, Circulation.
[375] C. Lory,et al. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation , 2011, Critical care.
[376] Daniel Polsky,et al. Coronary revascularization trends in the United States, 2001-2008. , 2011, JAMA.
[377] M. Jeong,et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. , 2011, The New England journal of medicine.
[378] D. Berman,et al. Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.
[379] C. O'connor,et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.
[380] Sunil V. Rao,et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.
[381] Gregg W Stone,et al. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. , 2011, Journal of the American College of Cardiology.
[382] A. Jacobs,et al. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). , 2011, The American journal of cardiology.
[383] M. Sabatier,et al. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. , 2011, The Journal of thoracic and cardiovascular surgery.
[384] P. Serruys,et al. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[385] M. Mamas,et al. A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis. , 2011, Journal of interventional cardiology.
[386] Guido Germano,et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. , 2011, European heart journal.
[387] M. Mamas,et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis. , 2011, European heart journal.
[388] Olaf Franzen,et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention , 2011, Clinical Research in Cardiology.
[389] N. Schork,et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.
[390] M. Carrier,et al. Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. , 2011, The Annals of thoracic surgery.
[391] Jun-Jie Zhang,et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. , 2011, Journal of the American College of Cardiology.
[392] M. Leesar,et al. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: A comprehensive meta‐analysis of randomized trials and observational studies comprising 7,994 patients , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[393] M. Zenati,et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. , 2011, The Journal of thoracic and cardiovascular surgery.
[394] G. Stone,et al. Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. , 2011, The American journal of cardiology.
[395] T. Maruo,et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. , 2011, JACC. Cardiovascular interventions.
[396] Dick M. Goedhart,et al. Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial , 2011, Circulation. Cardiovascular interventions.
[397] R. Damiano,et al. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. , 2011, The Journal of thoracic and cardiovascular surgery.
[398] J. D. de Lemos,et al. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. , 2011, JACC. Cardiovascular interventions.
[399] G. Schuler,et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. , 2011, Journal of the American College of Cardiology.
[400] C. Bhamidipati,et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. , 2011, The Journal of thoracic and cardiovascular surgery.
[401] Saibal Kar,et al. Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.
[402] E. Blackstone,et al. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. , 2011, JAMA.
[403] R. Virmani,et al. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. , 2011, Journal of the American College of Cardiology.
[404] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[405] M. Niemelä,et al. Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting: The Nordic-Baltic Bifurcation Study III , 2011, Circulation.
[406] Matti Niemelä,et al. Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study , 2011, Circulation. Cardiovascular interventions.
[407] F. Eberli,et al. Drug-eluting versus bare-metal stents in large coronary arteries. , 2010, The New England journal of medicine.
[408] Y. Choi,et al. Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. , 2010, Journal of the American College of Cardiology.
[409] D. Mukherjee,et al. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis. , 2010, JACC. Cardiovascular interventions.
[410] I. Koniari,et al. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review , 2010, Journal of cardiothoracic surgery.
[411] K. Harjai,et al. Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study , 2010, PloS one.
[412] D. Ardissino,et al. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis , 2010, Circulation.
[413] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[414] H. Krumholz,et al. Putting ad hoc PCI on pause. , 2010, JAMA.
[415] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.
[416] G. Montalescot,et al. New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis. , 2010, Journal of the American College of Cardiology.
[417] L. Cohn,et al. Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft , 2010, Current opinion in cardiology.
[418] J. Ferrières,et al. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. , 2010, The Journal of clinical endocrinology and metabolism.
[419] J. Rawn,et al. Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[420] Seung‐Jung Park,et al. Clinical ResearchInterventional CardiologyLong-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 10-Year Results of Bare-Metal Stents and 5-Year Results of Drug-Eluting Stents From the ASAN–MAIN (ASAN Medical Center–Left MAIN Revas , 2010 .
[421] Seung‐Jung Park,et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. , 2010, Journal of the American College of Cardiology.
[422] E. Antman,et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis , 2010, The Lancet.
[423] J. Vincent,et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. , 2010, JAMA.
[424] F. Neumann,et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. , 2010, Journal of the American College of Cardiology.
[425] S. Yusuf,et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.
[426] H. Katus,et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. , 2010, Journal of the American College of Cardiology.
[427] G. Stone,et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2010, JACC. Cardiovascular interventions.
[428] A. Kastrati,et al. ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention. , 2010, European heart journal.
[429] D. Hoffman,et al. Radial artery conduits improve long-term survival after coronary artery bypass grafting. , 2010, The Annals of thoracic surgery.
[430] L. Bojö,et al. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[431] D. Altman,et al. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). , 2010, European heart journal.
[432] Sunil V. Rao,et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. , 2010, JAMA.
[433] L. Køber,et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.
[434] Michael Böhm,et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.
[435] B. Gersh,et al. Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2010, Circulation.
[436] S. Yusuf,et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. , 2010, The New England journal of medicine.
[437] P. Kolh,et al. Guidelines on myocardial revascularization. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[438] P. Armstrong,et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. , 2010, European heart journal.
[439] G. Schuler,et al. Timing of invasive treatment after fibrinolysis in ST elevation myocardial infarction – a meta-analysis of immediate or early routine versus deferred or ischemia-guided randomised controlled trials , 2010, Heart.
[440] V. Pasceri,et al. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. , 2010, Journal of the American College of Cardiology.
[441] H. Sipilä,et al. Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.
[442] M. Hochadel,et al. Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[443] P. Kolh,et al. Experience with revascularization procedures does matter: low volume means worse outcome. , 2010, European heart journal.
[444] P. Post,et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. , 2010, European heart journal.
[445] I. Belenkie,et al. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[446] M. Elayda,et al. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. , 2010, The American journal of cardiology.
[447] F. Carre,et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. , 2010, European heart journal.
[448] Volker Klauss,et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. , 2010, The New England journal of medicine.
[449] C. Acar,et al. Long-term (5- to 20-year) patency of the radial artery for coronary bypass grafting. , 2010, The Journal of thoracic and cardiovascular surgery.
[450] R. Starzyk,et al. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. , 2010, JACC. Cardiovascular interventions.
[451] P. Armstrong,et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. , 2010, European heart journal.
[452] J. Afilalo,et al. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. , 2010, American heart journal.
[453] P. Kurlansky,et al. Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups. , 2010, The Annals of thoracic surgery.
[454] Jeroen J. Bax,et al. Prognostic importance of strain and strain rate after acute myocardial infarction. , 2010, European heart journal.
[455] Michael D Hill,et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.
[456] M. Mack,et al. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2010, Circulation.
[457] A. Kastrati,et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. , 2010, Journal of the American College of Cardiology.
[458] P. Kirchhof,et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a , 2010, European heart journal.
[459] R. Kornowski,et al. The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. , 2010, The Journal of thoracic and cardiovascular surgery.
[460] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.
[461] P. Stella,et al. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. , 2010, Journal of the American College of Cardiology.
[462] P. Fitzgerald,et al. A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study. , 2010 .
[463] X. Jouven,et al. Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.
[464] Elizabeth R DeLong,et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.
[465] Gregg W Stone,et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. , 2010, The New England journal of medicine.
[466] C. Macaya,et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.
[467] L. Mauri,et al. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). , 2010, The American journal of cardiology.
[468] M. Jeong,et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. , 2010, The New England journal of medicine.
[469] J. Spertus,et al. Quantifying the Early Health Status Benefits of Successful Chronic Total Occlusion Recanalization: Results From the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial , 2010, Circulation. Cardiovascular quality and outcomes.
[470] E. Ohman,et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.
[471] U. Christians,et al. Polymer-Free Biolimus A9–Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model , 2010, Circulation. Cardiovascular interventions.
[472] L. Menicanti,et al. End‐systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy , 2010, European journal of heart failure.
[473] D. Delurgio,et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.
[474] Stenting Study,et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial , 2010, The Lancet.
[475] J. Tu,et al. Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief , 2010, Annals of Internal Medicine.
[476] A. Baumbach,et al. Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions: The British Bifurcation Coronary Study: Old, New, and Evolving Strategies , 2010, Circulation.
[477] M. Mack,et al. On-pump versus off-pump CABG. , 2010, The New England journal of medicine.
[478] P. Damman,et al. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. , 2010, Journal of the American College of Cardiology.
[479] S. de Servi,et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. , 2010, British journal of anaesthesia.
[480] F. Neumann,et al. Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents. , 2010, American heart journal.
[481] C. Terkelsen,et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.
[482] V. Deneer,et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.
[483] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.
[484] A. Iñíguez-Romo,et al. Szabo technique versus conventional angiographic placement in bifurcations 010-001 of Medina and in aorto-ostial stenting: angiographic and procedural results. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[485] Y. Hayashi,et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). , 2010, JACC. Cardiovascular interventions.
[486] Ansar Hassan,et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting. , 2010, The Annals of thoracic surgery.
[487] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.
[488] Jeffrey Gold,et al. Adherence of Catheterization Laboratory Cardiologists to American College of Cardiology/American Heart Association Guidelines for Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery: What Happens in Actual Practice? , 2010, Circulation.
[489] P. Smits,et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial , 2010, The Lancet.
[490] A. Kastrati,et al. Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality. , 2010, The American journal of cardiology.
[491] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.
[492] K. Schulman,et al. Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries , 2010, Circulation.
[493] Samin K. Sharma,et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. , 2010, JACC. Cardiovascular interventions.
[494] Regina M. Hardison,et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.
[495] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.
[496] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[497] A. Shroyer,et al. On-pump versus off-pump coronary-artery bypass surgery. , 2009, The New England journal of medicine.
[498] R. Califf,et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. , 2009, The New England journal of medicine.
[499] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.
[500] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.
[501] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[502] Stephan Willems,et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.
[503] Deepak L. Bhatt,et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. , 2009, JAMA.
[504] H. Calkins,et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. , 2009, Journal of the American College of Cardiology.
[505] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.
[506] J. Mega,et al. Abstract 2126: CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis , 2009 .
[507] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. , 2009, JACC. Cardiovascular interventions.
[508] G. De Luca,et al. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials , 2009, European heart journal.
[509] Jeroen J. Bax,et al. Combined non-invasive anatomical and functional assessment with MSCT and MRI for the detection of significant coronary artery disease in patients with an intermediate pre-test likelihood , 2009, Heart.
[510] M. Tendera,et al. Clinical ResearchInterventional CardiologyEarly and Long-Term Results of Unprotected Left Main Coronary Artery Stenting: The LE MANS (Left Main Coronary Artery Stenting) Registry , 2009 .
[511] P. Teirstein,et al. Three‐year outcome of drug‐eluting stent implantation for coronary artery bifurcation lesions , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[512] T. Vassiliades,et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. , 2009, The Annals of thoracic surgery.
[513] F. Van de Werf,et al. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. , 2009, American heart journal.
[514] E. Topol,et al. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. , 2009, JACC. Cardiovascular interventions.
[515] A. Kastrati,et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. , 2009, European heart journal.
[516] G. Sangiorgi,et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up , 2009, Heart.
[517] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.
[518] F. Mohr,et al. Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery? , 2009, Circulation.
[519] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[520] G. Ambrosio,et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. , 2009, Journal of the American College of Cardiology.
[521] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.
[522] N. Curzen,et al. Percutaneous coronary intervention of ostial lesions. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[523] Yuebing Li,et al. Strokes after cardiac surgery and relationship to carotid stenosis. , 2009, Archives of neurology.
[524] P. Serruys,et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.
[525] Deepak L. Bhatt,et al. Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results From the Get With the Guidelines Program , 2009, Circulation.
[526] F. Neumann,et al. Sirolimus-Eluting Stent Treatment at High-Volume Centers Confers Lower Mortality at 6-Month Follow-Up: Results From the Prospective Multicenter German Cypher Registry , 2009, Circulation.
[527] Sunil V. Rao,et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). , 2009, The American journal of cardiology.
[528] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[529] D. Bainbridge,et al. The Efficacy of an Intraoperative Cell Saver During Cardiac Surgery: A Meta-Analysis of Randomized Trials , 2009, Anesthesia and analgesia.
[530] K. Thygesen,et al. How to set up an effective national primary angioplasty network: lessons learned from five European countries. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[531] P. Armstrong,et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. , 2009, European heart journal.
[532] J. Mega,et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial , 2009, The Lancet.
[533] Sean M. O'Brien,et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. , 2009, The Annals of thoracic surgery.
[534] P. Touboul,et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.
[535] J. Spertus,et al. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). , 2009, JACC. Cardiovascular interventions.
[536] E. Hannan,et al. Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies , 2009, Circulation.
[537] G. Pelissero,et al. Risk of Assessing Mortality Risk in Elective Cardiac Operations: Age, Creatinine, Ejection Fraction, and the Law of Parsimony , 2009, Circulation.
[538] G. Schuler,et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. , 2009, Journal of the American College of Cardiology.
[539] Ralf Degenhardt,et al. Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis , 2009, Circulation.
[540] Regina M. Hardison,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[541] Deepak L. Bhatt,et al. Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial , 2009, Circulation.
[542] G. Montalescot,et al. Can we override clopidogrel resistance? , 2009, Circulation.
[543] V. Aboyans,et al. Indications for carotid screening in patients with coronary artery disease. , 2009, Presse medicale.
[544] W. Wijns,et al. On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. , 2009, JACC. Cardiovascular interventions.
[545] H. Bøtker,et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. , 2009, European heart journal.
[546] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.
[547] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[548] J. Maselli,et al. Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery , 2009, Annals of Internal Medicine.
[549] A. Kastrati,et al. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. , 2009, Journal of the American College of Cardiology.
[550] C. Reid,et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. , 2009, The Annals of thoracic surgery.
[551] G. Mancia,et al. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal , 2009, Journal of hypertension.
[552] B. Lytle,et al. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. , 2009, The Annals of thoracic surgery.
[553] Christopher M O'Connor,et al. Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.
[554] F. Verheugt,et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.
[555] Young-Hak Kim,et al. Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.
[556] S. Nekolla,et al. Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial , 2009, Circulation.
[557] Sunil V. Rao,et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.
[558] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.
[559] A. Kastrati,et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. , 2009, JACC. Cardiovascular interventions.
[560] Alice Jacobs,et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions. , 2009, JACC. Cardiovascular interventions.
[561] R. Featherstone,et al. Randomized Controlled Trials Comparing Endarterectomy and Endovascular Treatment for Carotid Artery Stenosis: A Cochrane Systematic Review , 2009, Stroke.
[562] P. Fitzgerald,et al. 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. , 2009, Journal of the American College of Cardiology.
[563] Thomas A Trikalinos,et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis , 2009, The Lancet.
[564] Patrick W Serruys,et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods , 2009, The Lancet.
[565] J. Fajadet,et al. Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[566] E. Antman,et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.
[567] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.
[568] P. Myles,et al. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. , 2009, British journal of anaesthesia.
[569] G. Baron,et al. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. , 2009, American heart journal.
[570] Sanjay Kaul,et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. , 2009, The American journal of medicine.
[571] F. Fedele,et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. , 2009, Journal of the American College of Cardiology.
[572] G. Montalescot,et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.
[573] John A McPherson,et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. , 2009, Journal of the American College of Cardiology.
[574] F. Fedele,et al. Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study , 2008, European heart journal.
[575] Mathias Prokop,et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. , 2008, Journal of the American College of Cardiology.
[576] Deepak L. Bhatt,et al. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. , 2008, European heart journal.
[577] D. Dudek,et al. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. , 2008, European heart journal.
[578] G. Schuler,et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. , 2008, European heart journal.
[579] M. Budoff,et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Indi , 2008, Journal of the American College of Cardiology.
[580] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[581] M. Banach,et al. Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival , 2008, Circulation.
[582] D. Vaughan,et al. Hybrid cardiovascular procedures. , 2008, JACC. Cardiovascular interventions.
[583] M. Hori,et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. , 2008, JACC. Cardiovascular interventions.
[584] M. Perez,et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. , 2008, JACC. Cardiovascular interventions.
[585] D. Mark,et al. Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) , 2008, Journal of cardiovascular electrophysiology.
[586] J. Tijssen,et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? , 2008, European heart journal.
[587] F. Eberli,et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial , 2008, The Lancet.
[588] Adnan Kastrati,et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. , 2008, Journal of the American College of Cardiology.
[589] A. Shah,et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.
[590] M. Pfisterer,et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.
[591] J. Ottervanger,et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial , 2008, The Lancet.
[592] G. Montalescot. Mechanical reperfusion: treat well, treat on time too , 2008, The Lancet.
[593] A. Kastrati,et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. , 2008, The New England journal of medicine.
[594] Stanley E. Kaufman,et al. Effect of PCI on quality of life in patients with stable coronary disease. , 2008, The New England journal of medicine.
[595] A. Jaffe,et al. Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients , 2008, Circulation. Cardiovascular interventions.
[596] A. Jaffe,et al. Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary InterventionCLINICAL PERSPECTIVE , 2008 .
[597] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.
[598] F. Zijlstra,et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.
[599] G. Biondi-Zoccai,et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. , 2008, Journal of the American College of Cardiology.
[600] Antonio Colombo,et al. Bifurcation disease: what do we know, what should we do? , 2008, JACC. Cardiovascular interventions.
[601] B. Gersh,et al. Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.
[602] E. Topol,et al. Facilitated PCI in patients with ST-elevation myocardial infarction. , 2008, The New England journal of medicine.
[603] M. Fromm,et al. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. , 2008, Journal of the American College of Cardiology.
[604] Michail I. Papafaklis,et al. European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[605] S. Jain,et al. Biodegradable-polymer-based, sirolimus-eluting Supralimus stent: 6-month angiographic and 30-month clinical follow-up results from the series I prospective study. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[606] P. Kuchynka,et al. Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 , 2008, European heart journal.
[607] M. Böhm,et al. Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008 , 2008, Clinical Research in Cardiology.
[608] R. Mehta,et al. Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. , 2008, The American journal of cardiology.
[609] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[610] Patrick W Serruys,et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial , 2008, The Lancet.
[611] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[612] S. Yusuf,et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.
[613] D. Yuh,et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. , 2008, The Journal of thoracic and cardiovascular surgery.
[614] E. Steyerberg,et al. Do we need separate risk stratification models for hospital mortality after heart valve surgery? , 2008, The Annals of thoracic surgery.
[615] G. Lip,et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.
[616] M. Flather,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.
[617] A. J. O’Malley,et al. Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients , 2008, Circulation.
[618] A. van Rossum,et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.
[619] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.
[620] L. Rydén,et al. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. , 2007, European heart journal.
[621] S. Steinhubl,et al. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. , 2007, Archives of internal medicine.
[622] J. Ware,et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. , 2007, JAMA.
[623] J. Dunning,et al. Does bilateral internal thoracic artery harvest increase the risk of mediastinitis? , 2007, Interactive cardiovascular and thoracic surgery.
[624] Reza Ardehali,et al. Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery , 2007, Annals of Internal Medicine.
[625] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[626] André Lamy,et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.
[627] A. Moss,et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.
[628] Shaosong Zhang,et al. Strategies to reduce intraluminal clot formation in endoscopically harvested saphenous veins. , 2007, The Journal of thoracic and cardiovascular surgery.
[629] Marco Valgimigli,et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.
[630] S. Yusuf,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. , 2007, Journal of the American College of Cardiology.
[631] C. Rogers,et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. , 2007, Journal of the American College of Cardiology.
[632] R. Carlos,et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. , 2007, Journal of the American College of Cardiology.
[633] E. Rahme,et al. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. , 2007, The Annals of thoracic surgery.
[634] D. Berman,et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. , 2007, Journal of the American College of Cardiology.
[635] Simon Wandel,et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.
[636] Timothy D. Henry,et al. A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.
[637] W. Laskey,et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.
[638] J. Tanigawa,et al. Retrograde approach to coronary chronic total occlusions: preliminary single European centre experience. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[639] R. Dietz,et al. Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) , 2007, Heart.
[640] H. Krumholz,et al. Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications , 2007, Circulation.
[641] C. Granger,et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. , 2007, Archives of internal medicine.
[642] B. Gersh,et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. , 2007, European heart journal.
[643] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[644] William Wijns,et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.
[645] A. Schoenenberger,et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. , 2007, JAMA.
[646] Bernard Chevalier,et al. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[647] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[648] Sebastian Kelle,et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.
[649] P. Lesault,et al. Six-Month Outcome of Emergency Percutaneous Coronary Intervention in Resuscitated Patients After Cardiac Arrest Complicating ST-Elevation Myocardial Infarction , 2007, Circulation.
[650] Seung‐Jung Park,et al. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease. , 2007, The American journal of cardiology.
[651] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.
[652] Marco Valgimigli,et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.
[653] B. Gersh,et al. Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2007, Circulation.
[654] A. Darzi,et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery , 2007, BMJ : British Medical Journal.
[655] R. Higgins,et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. , 2007, The Annals of thoracic surgery.
[656] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.
[657] B. Brodie,et al. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. , 2007, The American journal of cardiology.
[658] D. Moliterno,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.
[659] A. Kastrati,et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. , 2007, Journal of the American College of Cardiology.
[660] G. Mannam,et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. , 2007, The Journal of thoracic and cardiovascular surgery.
[661] G. Lamas,et al. Coronary intervention for persistent occlusion after myocardial infarction. , 2006, The New England journal of medicine.
[662] J. Dunning,et al. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[663] A. Keech,et al. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.
[664] Harlan M Krumholz,et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. , 2006, The New England journal of medicine.
[665] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[666] M. Böhm,et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. , 2006, Clinical research in cardiology : official journal of the German Cardiac Society.
[667] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[668] Tom Treasure,et al. Off-Pump Surgery Is Associated With Reduced Occurrence of Stroke and Other Morbidity as Compared With Traditional Coronary Artery Bypass Grafting: A Meta-Analysis of Systematically Reviewed Trials , 2006, Stroke.
[669] Jeroen J. Bax,et al. A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[670] S. Bagshaw,et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. , 2006, The Annals of thoracic surgery.
[671] P. Serruys,et al. Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[672] M. Niemelä,et al. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study , 2006, Circulation.
[673] R. Califf,et al. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes. , 2006, Journal of the American College of Cardiology.
[674] G. Montalescot,et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. , 2006, Journal of the American College of Cardiology.
[675] Deepak L. Bhatt,et al. FOCUS ISSUE: CARDIAC INTERVENTION Intervention in Acute Coronary Syndromes Benefit of Early Invasive Therapy in Acute Coronary Syndromes A Meta-Analysis of Contemporary Randomized Clinical Trials , 2006 .
[676] R. Califf,et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. , 2006, The Annals of thoracic surgery.
[677] L. Wallentin,et al. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study , 2006, The Lancet.
[678] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. , 2006, The New England journal of medicine.
[679] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.
[680] G. Montalescot,et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. , 2006, Journal of the American College of Cardiology.
[681] L. Mauri,et al. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. , 2006, American heart journal.
[682] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.
[683] P. Steg,et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry , 2006, Heart.
[684] J. Brinker,et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.
[685] Mark Stevenson,et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. , 2006, Health technology assessment.
[686] D. Berman,et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. , 2006, Journal of the American College of Cardiology.
[687] P. Monteiro. Impact of Early Coronary Artery Bypass Graft in an Unselected Acute Coronary Syndrome Patient Population , 2006, Circulation.
[688] R. Erbel,et al. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[689] E. Tsuchikane,et al. New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. , 2006, The Journal of invasive cardiology.
[690] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.
[691] C. Macaya,et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. , 2006, Journal of the American College of Cardiology.
[692] M. Graham,et al. Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery. , 2006, The Canadian journal of cardiology.
[693] J. Critchley,et al. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[694] Samin K. Sharma,et al. Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.
[695] G. Maurer,et al. Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry) , 2006, Circulation.
[696] A. Moss,et al. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.
[697] C. Di Mario,et al. Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[698] A. Pappalardo,et al. The impact of epiaortic ultrasonographic scanning on the risk of perioperative stroke. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[699] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.
[700] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.
[701] A. Kastrati,et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. , 2006, JAMA.
[702] E. Boersma,et al. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. , 2006, European heart journal.
[703] D. Altman,et al. Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265] , 2006, Trials.
[704] S. Stegher,et al. Dual Antiplatelet Regime Versus Acetyl-acetic Acid for Carotid Artery Stenting , 2006, CardioVascular and Interventional Radiology.
[705] J. Boura,et al. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials , 2006, The Lancet.
[706] F. Veglia,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of medicine.
[707] Alfonso Medina,et al. Una clasificación simple de las lesiones coronarias en bifurcación , 2006 .
[708] J. Suárez de Lezo,et al. [A new classification of coronary bifurcation lesions]. , 2006, Revista espanola de cardiologia.
[709] K R Abrams,et al. Systematic review and evaluation of methods of assessing urinary incontinence. , 2006, Health technology assessment.
[710] H. Krumholz,et al. Relation Between Hospital Specialization With Primary Percutaneous Coronary Intervention and Clinical Outcomes in ST-Segment Elevation Myocardial Infarction: National Registry of Myocardial Infarction-4 Analysis , 2006, Circulation.
[711] Jörg Hausleiter,et al. Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss , 2006, Circulation.
[712] P. Poole‐Wilson,et al. Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease , 2006, Scandinavian cardiovascular journal : SCJ.
[713] A. Baumbach,et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. , 2005, The New England journal of medicine.
[714] K. Alexander,et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.
[715] Colin Baigent,et al. Low-dose aspirin for the prevention of atherothrombosis. , 2005, The New England journal of medicine.
[716] G. Schuler,et al. Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: A 5-Year Follow-Up , 2005, Circulation.
[717] Prevent Iv Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .
[718] A. Kastrati,et al. Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial , 2005, Circulation.
[719] B. Lytle,et al. Is reoperation still a risk factor in coronary artery bypass surgery? , 2005, The Annals of thoracic surgery.
[720] Lisa Hartling,et al. Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.
[721] I. Iakovou,et al. Contemporary stent treatment of coronary bifurcations. , 2005, Journal of the American College of Cardiology.
[722] R. Holloway,et al. Carotid endarterectomy—An evidence-based review , 2005, Neurology.
[723] Samin K. Sharma,et al. Volume-Outcome Relationships for Percutaneous Coronary Interventions in the Stent Era , 2005, Circulation.
[724] Deepak L. Bhatt,et al. Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). , 2005, The American journal of cardiology.
[725] H. Boshuizen,et al. Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.
[726] G. Wells,et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). , 2005, Journal of the American College of Cardiology.
[727] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[728] S. Nekolla,et al. Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial , 2005 .
[729] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.
[730] J. Ioannidis,et al. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis , 2005, Circulation.
[731] R. Habib,et al. Is hospital procedure volume a reliable marker of quality for coronary artery bypass surgery? A comparison of risk and propensity adjusted operative and midterm outcomes. , 2005, The Annals of thoracic surgery.
[732] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[733] P. Gaines,et al. The benefits of combined anti-platelet treatment in carotid artery stenting. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[734] R. Christofferson,et al. Effect of chronic total coronary occlusion on treatment strategy. , 2005, The American journal of cardiology.
[735] G. Stone,et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. , 2005, Journal of the American College of Cardiology.
[736] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[737] Thomas E. Moritz,et al. Coronary-artery revascularization before elective major vascular surgery , 2005 .
[738] Antonio Colombo,et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. , 2005, European heart journal.
[739] A. Sajadieh,et al. Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. , 2005, European heart journal.
[740] R. Gibbons,et al. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial , 2005 .
[741] P. Serruys,et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). , 2005, American heart journal.
[742] Yingxing Wu,et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. , 2005, The Journal of thoracic and cardiovascular surgery.
[743] P. Steg,et al. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. , 2005, The American journal of cardiology.
[744] A. Cohen-Solal,et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.
[745] P. Serruys,et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. , 2005, The American journal of cardiology.
[746] A. Kastrati,et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.
[747] E. Tuzcu,et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease , 2005 .
[748] Randall C. Thompson,et al. Predictors of Quality-of-Life Benefit After Percutaneous Coronary Intervention , 2004, Circulation.
[749] F. Loop,et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. , 2004, The Annals of thoracic surgery.
[750] C David Naylor,et al. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. , 2004, The New England journal of medicine.
[751] B. Hemmelgarn,et al. Survival After Coronary Revascularization Among Patients With Kidney Disease , 2004, Circulation.
[752] O. Penn,et al. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[753] F. Fernández‐Avilés,et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.
[754] P. Poole‐Wilson,et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial , 2004, The Lancet.
[755] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[756] P. Pellikka,et al. Prognostic value of exercise echocardiography in patients with classic angina pectoris. , 2004, The American journal of cardiology.
[757] I. Iakovou,et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. , 2004, Journal of the American College of Cardiology.
[758] E. Topol,et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. , 2004, JAMA.
[759] H. Burri,et al. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[760] R. Califf,et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.
[761] R. Ferrari,et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. , 2004, Journal of the American College of Cardiology.
[762] A. Collins,et al. Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures , 2004, Circulation.
[763] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[764] B. Gersh,et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. , 2004, Journal of the American College of Cardiology.
[765] S. Ebrahim,et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.
[766] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.
[767] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[768] T. Harr,et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.
[769] E. Topol,et al. Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. , 2004, European heart journal.
[770] A. Kastrati,et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. , 2004, The New England journal of medicine.
[771] E. DeLong,et al. Procedural volume as a marker of quality for CABG surgery. , 2004, JAMA.
[772] M. Bonardi,et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study , 2004, International journal of cardiovascular interventions.
[773] Diederick Grobbee,et al. Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty , 2003, Circulation.
[774] P. Touboul,et al. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.
[775] J. Birkmeyer,et al. Surgeon volume and operative mortality in the United States. , 2003, The New England journal of medicine.
[776] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[777] M. Dalby,et al. Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.
[778] G. Marenzi,et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.
[779] J. Bermejo,et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. , 2003, Journal of the American College of Cardiology.
[780] Deepak L. Bhatt,et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival , 2003 .
[781] S. Pocock,et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. , 2003, Journal of the American College of Cardiology.
[782] A. Kastrati,et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[783] U. Zeymer,et al. Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease: A Study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte , 2003, Circulation.
[784] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.
[785] K. Fox,et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) , 2003, The Lancet.
[786] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.
[787] C. Macaya,et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. , 2003, Journal of the American College of Cardiology.
[788] Robert M Califf,et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. , 2003, Journal of the American Society of Nephrology : JASN.
[789] Klaus Rasmussen,et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.
[790] C. Hofer,et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.
[791] G. Stone,et al. Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.
[792] J. Critchley,et al. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.
[793] U. Siebert,et al. Impact of intravascular ultrasound‐guided stenting on long‐term clinical outcome: A meta‐analysis of available studies comparing intravascular ultrasound‐guided and angiographically guided stenting , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[794] D. Berman,et al. Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.
[795] J. Brophy,et al. Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis , 2003, Annals of Internal Medicine.
[796] L. Sleeper,et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry , 2003 .
[797] S. Nashef,et al. The logistic EuroSCORE , 2003 .
[798] B. Pitt,et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. , 2003, The New England journal of medicine.
[799] H. White,et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.
[800] M. Pfisterer,et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. , 2003, JAMA.
[801] G. Schuler,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.
[802] A. Delago,et al. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention , 2003 .
[803] Eugenio Picano,et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. , 2003, Journal of the American College of Cardiology.
[804] P. Aspelin,et al. Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.
[805] L. Shaw,et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[806] Eugene Crystal,et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. , 2003, American heart journal.
[807] Deepak L. Bhatt,et al. Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized Clinical Trials , 2002, Circulation.
[808] Jerome Sacks,et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. , 2002, Journal of the American College of Cardiology.
[809] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[810] S. Ellis,et al. Emergency Coronary Artery Bypass Surgery in the Contemporary Percutaneous Coronary Intervention Era , 2002, Circulation.
[811] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.
[812] Ameet Bakhai,et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.
[813] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[814] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[815] J. Goldstein. Pathophysiology and management of right heart ischemia. , 2002, Journal of the American College of Cardiology.
[816] R. Califf,et al. Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.
[817] Joseph P Desimone,et al. Long-term survival of dialysis patients after coronary bypass grafting. , 2002, The Annals of thoracic surgery.
[818] E. Amsterdam,et al. Immediate Exercise Testing to Evaluate Low‐Risk Patients Presenting to the Emergency Department with Chest Pain. , 2002, Journal of the American College of Cardiology.
[819] S. Yusuf,et al. Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-Analysis , 2002, Circulation.
[820] L. Shaw,et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.
[821] M. Dashwood,et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. , 2002, The Annals of thoracic surgery.
[822] Thomas L. Lenz,et al. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. , 2002, Chest.
[823] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.
[824] M. Leon,et al. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.
[825] Jiang He,et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.
[826] J. López-Sendón,et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. , 2002, Journal of the American College of Cardiology.
[827] L. Schwartz,et al. The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions. , 2002, The Journal of invasive cardiology.
[828] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.
[829] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[830] R. Peto,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[831] A. Serra,et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.
[832] R. Kaplan,et al. Volume-Outcome Relation for Physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State , 2001, Circulation.
[833] D. Exner,et al. Prior Coronary Artery Bypass Surgery and Risk of Death Among Patients With Ischemic Left Ventricular Dysfunction , 2001, Circulation.
[834] The Time Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.
[835] Douglas G Altman,et al. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries , 2001, The Lancet.
[836] J. Birkmeyer,et al. Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. , 2001, Surgery.
[837] J. Lasala,et al. Randomized Comparison of Ticlopidine and Clopidogrel After Intracoronary Stent Implantation in a Broad Patient Population , 2001, Circulation.
[838] L. D. Saunders,et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. , 2001, American heart journal.
[839] Mitchell W. Krucoff,et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.
[840] P. Pellikka,et al. Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. , 2001, The American journal of medicine.
[841] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.
[842] E. Braunwald,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.
[843] A. Kastrati,et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.
[844] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[845] K. Detre,et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.
[846] F Unger,et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.
[847] B. Lytle. Skeletonized internal thoracic artery grafts and wound complications. , 2001, The Journal of thoracic and cardiovascular surgery.
[848] C. Tracy,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.
[849] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.
[850] D. Wennberg,et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. , 2000, JAMA.
[851] G. O'connor,et al. Risks of Morbidity and Mortality in Dialysis Patients Undergoing Coronary Artery Bypass Surgery , 2000, Circulation.
[852] R. Califf,et al. Lack of progress in cardiogenic shock: lessons from the GUSTO trials , 2000 .
[853] P. Steg,et al. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. , 2000, International journal of cardiology.
[854] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.
[855] J. Hochman,et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? , 2000, Journal of the American College of Cardiology.
[856] L. Sleeper,et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.
[857] H. White,et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.
[858] S. Yusuf,et al. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry , 2000, Circulation.
[859] M. Bertrand,et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000, Circulation.
[860] G. Guyatt,et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials , 2000, BMJ : British Medical Journal.
[861] H A Feldman,et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. , 2000, JAMA.
[862] F. Loop,et al. Surgery for Acquired Cardiovascular DiseaseIsolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: Late consequences of incomplete revascularization☆☆☆ , 2000 .
[863] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[864] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[865] V. Ho,et al. Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. , 2000, Circulation.
[866] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[867] J. Cox,et al. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. , 1999, The Journal of thoracic and cardiovascular surgery.
[868] H. Schäfers,et al. T grafts with the right internal thoracic artery to left internal thoracic artery versus the left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery main stem. , 1999, The Journal of thoracic and cardiovascular surgery.
[869] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[870] Alan M. Johnson,et al. Port-access coronary artery bypass grafting: technique and comparative results. , 1999, The Annals of thoracic surgery.
[871] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[872] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[873] D. Waters,et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.
[874] S. Lemeshow,et al. European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[875] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[876] T. Muramatsu,et al. Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. , 1999, The Journal of invasive cardiology.
[877] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[878] S. Pocock,et al. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .
[879] K. Wegscheider,et al. Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of Thrombolysis. , 1998, Journal of the American College of Cardiology.
[880] A. Kastrati,et al. Operator volume and outcome of patients undergoing coronary stent placement. , 1998, Journal of the American College of Cardiology.
[881] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[882] C. Dennis,et al. The Electrocardiographic Exercise Test in a Population with Reduced Workup Bias: Diagnostic Performance, Computerized Interpretation, and Multivariable Prediction , 1998, Annals of Internal Medicine.
[883] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[884] Bigger Jt,et al. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .
[885] W. O’Neill,et al. Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. , 1997, Catheterization and cardiovascular diagnosis.
[886] RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.
[887] E. Blackstone,et al. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. K.U. Leuven Coronary Surgery Program. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[888] J. Dhainaut,et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.
[889] N. Geller,et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.
[890] U. Sigwart,et al. Cutting balloon angioplasty and stenting for aorto-ostial lesions. , 1997, Heart.
[891] Eric Boersma,et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.
[892] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[893] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.
[894] R. Califf,et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. , 1996, The Journal of thoracic and cardiovascular surgery.
[895] M. Hadamitzky,et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.
[896] R. Califf,et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.
[897] CABRI Trial Participants,et al. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) , 1995, The Lancet.
[898] B. Chaitman,et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. , 1995, Circulation.
[899] D. Baker,et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. , 1994 .
[900] E. Topol,et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.
[901] C. Hamm,et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.
[902] M. Kutner,et al. A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .
[903] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.
[904] F. Loop,et al. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. , 1994, The Journal of thoracic and cardiovascular surgery.
[905] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[906] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[907] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[908] B. Iung,et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. , 1993, The Journal of heart valve disease.
[909] L. Wallentin,et al. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. , 1993, International journal of cardiology.
[910] RITA-2 trial participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.
[911] M. Leon,et al. Rotational coronary atherectomy of ostial stenoses. , 1993, The American journal of cardiology.
[912] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[913] H. Hecht,et al. Lesion morphology and coronary angioplasty: current experience and analysis. , 1992, Journal of the American College of Cardiology.
[914] J. López-Sendón,et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. , 1992, Journal of the American College of Cardiology.
[915] P. Hartigan,et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.
[916] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[917] E. Topol,et al. Atherectomy of right coronary ostial stenoses: initial and long-term results, technical features and histologic findings. , 1991, The American journal of cardiology.
[918] T. Beauchamp,et al. Principles of biomedical ethics , 1991 .
[919] M. Knudsen,et al. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. , 1990, The Journal of thoracic and cardiovascular surgery.
[920] A. Jaffe,et al. Determinants of hemodynamic compromise with severe right ventricular infarction. , 1990, Circulation.
[921] M. Scott,et al. Management of acute coronary occlusion during percutaneous transluminal coronary angioplasty: experience of complications in a hospital without on site facilities for cardiac surgery. , 1990, BMJ.
[922] G. E. Green,et al. Clinical implications of internal mammary artery bypass grafts: the Coronary Artery Surgery Study experience. , 1988, Circulation.
[923] J. Matloff,et al. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. , 1988, The Journal of thoracic and cardiovascular surgery.
[924] W. Edwards,et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. , 1987, Journal of the American College of Cardiology.
[925] B. Gersh,et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. , 1986, Circulation.
[926] R. Thompson. Isolated coronary ostial stenosis in women. , 1986, Journal of the American College of Cardiology.
[927] W. C. Sheldon,et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.
[928] E. Passamani,et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. , 1985, The New England journal of medicine.
[929] R. O'rourke,et al. Right ventricular infarction: identification by hemodynamic measurements before and after volume loading and correlation with noninvasive techniques. , 1984, Journal of the American College of Cardiology.
[930] Cass Principal Investigators and Their Associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.
[931] A. Grüntzig. TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS , 1978, The Lancet.
[932] H. Barner,et al. Coronary Ostial Stenosis , 1975, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[933] V. Rissanen. Occurrence of coronary ostial stenosis in a necropsy series of myocardial infarction, sudden death, and violent death. , 1975, British heart journal.
[934] Orchard Tj. Letter: Mobile coronary care. , 1974 .
[935] R. Dinsmore,et al. Right ventricular infarction. Clinical diagnosis and differentiation from cardiac tamponade and pericardial constriction. , 1974, The American journal of cardiology.
[936] J. Cohn,et al. Right ventricular infarction. Clinical and hemodynamic features. , 1974, The American journal of cardiology.
[937] A Kantrowitz,et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. , 1968, JAMA.
[938] Elias Sanidas,et al. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. , 2014, JACC. Cardiovascular interventions.
[939] P. Serruys,et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted Fro , 2014, JACC. Cardiovascular interventions.
[940] F. Neumann,et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. , 2013, JACC. Cardiovascular interventions.
[941] D. Berman,et al. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. , 2013, European heart journal.
[942] G. Schuler,et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial. , 2013, JACC. Cardiovascular interventions.
[943] V. Lorenzoni,et al. Detection of Obstructive Coronary Artery Disease by Non Invasive Anatomical and Functional Imaging. Results of the Multicenter European EVINCI Study , 2013 .
[944] B. Gersh,et al. ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .
[945] H. Hammes,et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD , 2013 .
[946] C. Ronco,et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2012, The American journal of medicine.
[947] F. Veglia,et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. , 2012, JACC. Cardiovascular interventions.
[948] Samer A M Nashef,et al. EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[949] Nishant R. Shah,et al. Percutaneous Circulatory Support in Cardiogenic Shock: Interventional Bridge to Recovery , 2012, Circulation.
[950] K. Mahaffey,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .
[951] B. Rangan,et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[952] F. Mohr,et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. , 2011, The Journal of thoracic and cardiovascular surgery.
[953] A. Kastrati,et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. , 2011, European heart journal.
[954] T. Henry,et al. Causes of Delay and Associated Mortality in Patients Transferred With ST-Segment – Elevation Myocardial Infarction , 2011 .
[955] M. Zembala,et al. Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in MultI-vessel coronary artery DisEaSe (POLMIDES) - study design. , 2011, Kardiologia polska.
[956] G. Matalanis,et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. , 2010, The Journal of thoracic and cardiovascular surgery.
[957] M. Keltai,et al. Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .
[958] S. Khuri,et al. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. , 2009, The Annals of thoracic surgery.
[959] S. Abbara. Diagnostic Performance of Coronary Angiography by 64-Row CT , 2009 .
[960] G. Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2009 .
[961] K. Kawazoe,et al. Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[962] Deepak L. Bhatt,et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.
[963] John D Friedman,et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[964] P. Serruys,et al. Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention , 2006 .
[965] N. Smedira,et al. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. , 2006, The Journal of thoracic and cardiovascular surgery.
[966] B. Buxton,et al. Patencies of 2,127 arterial to coronary conduits over 15 years , 2004 .
[967] F. A. Lucchese,et al. Efetividade do metoprolol na prevenção de fibrilação e flutter atrial no pós-operatório de cirurgia de revascularização miocárdica , 2004 .
[968] J. Tanigawa,et al. Comparison of cutting balloon vs stenting alone in small branch ostial lesions of native coronary arteries. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[969] E. Bonnefoy,et al. Primary angioplasty vs. prehospital fibrinolysis in acute myocardial infarction: a randomised study☆ , 2003 .
[970] D. Berman,et al. Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease , 2002, Circulation.
[971] Caroline A Milton,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt , 2001 .
[972] I. Palacios,et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. , 2001, Journal of the American College of Cardiology.
[973] S. Nashef,et al. Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .
[974] T Walther,et al. Comparison of MIDCAP versus conventional CABG surgery regarding pain and quality of life. , 1999, The heart surgery forum.
[975] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[976] G. Miller,et al. Isolated coronary ostial stenosis. , 1986, Catheterization and cardiovascular diagnosis.
[977] Y. Arad,et al. Objectives Background Methods Results Conclusions , 2022 .
[978] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .
[979] P. Fitzgerald,et al. Prospective, Multicenter, Randomized Trial to ssess Efficacy of Pioglitazone on In-Stent eointimal Suppression in Type 2 Diabetes OPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study) , 2022 .